ABVX vs GILD: Which Stock is Better?
Side-by-side comparison of Abivax Sa and Gilead Sciences Inc in 2026
ABVX
Abivax Sa
$118.84
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ABVX | GILD | Winner |
|---|---|---|---|
| Market Cap | $8.19B | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | -0.8% | 0.0% | GILD |
| Gross Margin | 100.0% | 78.7% | ABVX |
Analyze ABVX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABVX or GILD a better investment?
Comparing ABVX and GILD: Abivax Sa has a market cap of $8.19B while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABVX and GILD?
ABVX (Abivax Sa) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABVX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABVX or GILD?
GILD has higher revenue growth at 0.0% vs -0.8% for ABVX.
Which company is more profitable: ABVX or GILD?
Abivax Sa (ABVX) has higher gross margins at 100.0% compared to 78.7% for GILD.
Which is the larger company: ABVX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $8.19B for ABVX.
Should I buy ABVX or GILD in 2026?
Both ABVX and GILD have investment merit. ABVX trades at $118.84 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABVX and GILD stock?
Key differences: Market Cap ($8.19B vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 78.7%).